Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug 20;32(24):2587-94.
doi: 10.1200/JCO.2013.55.0418.

Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations

Review

Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations

Arti Hurria et al. J Clin Oncol. .

Abstract

A majority of cancer diagnoses and deaths occur in patients age ≥ 65 years. With the aging of the US population, the number of older adults with cancer will grow. Although the coming wave of older patients with cancer was anticipated in the early 1980s, when the need for more research on the cancer-aging interface was recognized, many knowledge gaps remain when it comes to treating older and/or frailer patients with cancer. Relatively little is known about the best way to balance the risks and benefits of existing cancer therapies in older patients; however, these patients continue to be underrepresented in clinical trials. Furthermore, the available clinical trials often do not include end points pertinent to the older adult population, such as preservation of function, cognition, and independence. As part of its ongoing effort to advance research in the field of geriatric oncology, the Cancer and Aging Research Group held a conference in November 2012 in collaboration with the National Cancer Institute, the National Institute on Aging, and the Alliance for Clinical Trials in Oncology. The goal was to develop recommendations and establish research guidelines for the design and implementation of therapeutic clinical trials for older and/or frail adults. The conference sought to identify knowledge gaps in cancer clinical trials for older adults and propose clinical trial designs to fill these gaps. The ultimate goal of this conference series is to develop research that will lead to evidence-based care for older and/or frail adults with cancer.

PubMed Disclaimer

Conflict of interest statement

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

Figures

Fig 1.
Fig 1.
Age distribution for patients enrolled onto National Cancer Institute (NCI) adult cooperative group phase II and III treatment trials (all diseases) from 2001 to 2011. Percentage of patients enrolled in each age group is shown for each year, as reported by cooperative groups to the NCI Clinical Data Update System database (NCI Division of Cancer Treatment and Diagnosis) as of May 2012.

References

    1. Howlander N, Noone NA, Krapcho M, et al., editors. Cancer Statistics Review, 1975-2010. http://seer.cancer.gov/csr/1975_2010/
    1. Smith BD, Smith GL, Hurria A, et al. Future of cancer incidence in the United States: Burdens upon an aging, changing nation. J Clin Oncol. 2009;27:2758–2765. - PubMed
    1. Parry C, Kent EE, Mariotto AB, et al. Cancer survivors: A booming population. Cancer Epidemiol Biomarkers Prev. 2011;20:1996–2005. - PMC - PubMed
    1. Kennedy BJ. Aging and cancer. J Clin Oncol. 1988;6:1903–1911. - PubMed
    1. Yancik R, Carbone PP, editors. New York, NY: Raven Press; 1983. Perspectives on Prevention and Treatment of Cancer in the Elderly.

MeSH terms